key: cord-0730298-dvp27t98 authors: Bhansali, Suneet; Minocha, Prashant; Phoon, Colin; Henry, Gillian; Chakravarti, Sujata; Ramirez, Michelle; Bhatla, Puneet title: Cardiac involvement in a pediatric patient with COVID‐19: Looking beyond the nonspecific global cardiac injury date: 2020-08-08 journal: Echocardiography DOI: 10.1111/echo.14814 sha: 773c955eafd169acd220d16aff7c53dafaebbe83 doc_id: 730298 cord_uid: dvp27t98 We report a case of a 17‐year‐old healthy male presenting with multisystem hyperinflammatory shock temporally associated with COVID‐19. Cardiac involvement was suspected based on evidence of significant cardiac injury (elevated cardiac biomarkers, electrocardiographic and echocardiographic abnormalities). Cardiac magnetic resonance imaging was performed demonstrating global biventricular systolic dysfunction, as well as a small area of T2 hyperintensity and mid‐wall late gadolinium enhancement. This case discusses the varied cardiac involvement in pediatric patients with COVID‐19 infection and highlights that cardiac injury is not just limited to hyperinflammatory syndrome related global dysfunction but a more focal myocarditis can also be seen. Upon admission to the PICU, another CPOCUS study was performed using a Philips Lumify transducer which showed mildly decreased LV systolic function (LVEF of 43% by 5/6 area length method) and regional wall-motion abnormalities predominantly involving the mid-ventricular level inferior wall as well as the inferior septum (Movie S1). Cardiac magnetic resonance imaging (CMRI) was performed to further evaluate myocardial function and characterization; this confirmed the diminished LVEF of 40% and regional hypokinesia, but also showed mild systolic dysfunction of the right ventricle (RVEF of 39%). Additionally, CMRI showed a small area of mid-wall late gadolinium enhancement (LGE) involving the mid-ventricular level inferior septum at the inferior LV-RV junction ( Figure 2A ). This corresponded with the area of increased myocardial signal on T2-weighted fast spin-echo images ( Figure 2B ), suggestive of myocardial edema. Overall findings were consistent with global cardiac dysfunction but also confirmed focal inflammation of the myocardium. Hydroxychloroquine was initiated empirically for COVID-19 once the QTc was confirmed to be normal but was discontinued on Day 3 given QTc prolongation. He remained hemodynamically stable during his hospitalization without the use of vasopressors. His electrocardiographic abnormalities resolved, and troponin levels that peaked at 6.170 ng/mL were near normal by hospital Day 5 (Table 1) . He was discharged home on Day 5 of hospitalization with outpatient follow-up by cardiology. The 2019 novel coronavirus disease is caused by the SARS-CoV-2. The virus replicates in symptomatic and asymptomatic people and has resulted in more than 323 000 deaths worldwide as of May 20th, 2020 (https://coron avirus.jhu.edu/map.html). Disease presentation varies from nonspecific symptoms (fever, cough, sore throat, malaise, A, Phase-sensitive inversion recovery (PSIR) sequences in short-axis view show mid-wall late gadolinium enhancement involving the inferior septum at the mid-ventricular level (annotated by arrow). B, Turbo inversion recovery (TIRM) sequences in short-axis view shows small area of increased signal in the myocardium involving the inferior septum at the mid-ventricular level corresponding to the area of mid-wall late gadolinium enhancement (see Figure 2A ) suggestive of myocardial edema cardiac injury have also been commonly reported in these patients pointing toward a more global cardiac involvement as part of the hyperinflammatory shock syndrome. 7 None of these reports in children however describe concomitant focal myocarditis. Our case presented with focal electrocardiographic abnormalities (T-wave inversion in inferior leads) as well as regional wall-motion abnormalities on echocardiography prompting further investigation for other potential mechanisms of cardiac involvement, such as inflammation. Inflammation of cardiac muscle, or myocarditis, may be due to direct virus related injury to cardiomyocytes or as a consequence of indirect injury from systemic inflammatory response syndrome or ARDS-induced hypoxemia. 9 Currently, CMRI is the noninvasive gold standard to detect myocardial dysfunction, edema, and fibrosis, and to diagnose myocarditis. 10 Since its emergence in December 2019, there have been few reported cases of COVID-19 related myocarditis in adults, 6 but none in children. Due to focal electrocardiographic abnormalities, regional dysfunction on echocardiography, and reports of varying cardiovascular involvement in adults with COVID-19, we obtained a CMRI to further delineate the mechanism of cardiovascular involvement in our patient. CMRI confirmed a diagnosis of focal myocarditis (suggested by T2 hyperintensity and mid-wall LGE) apart from a previously well-described phenomenon of global cardiac dysfunction related to hyperinflammatory syndrome. In addition, CMRI provided other useful information in terms of diagnosing RV dysfunction (not well visualized by Lumify), and ruling out acute coronary syndrome, reported in adult patients. 6 In contrast to coronary involvement in children with multisystem inflammatory disease related to COVID-19 infection, 7 our patient had no coronary involvement, but rather cardiac dysfunction and features consistent with focal myocarditis. The authors have no conflicts of interest relevant to this article to disclose. The COVID-19 epidemic COVID-19 (Novel Coronavirus 2019) -recent trends COVID-19 and the cardiovascular system Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Cardiovascular disease and COVID-19 Description and proposed management of the acute COVID-19 cardiovascular syndrome Hyperinflammatory shock in children during COVID-19 pandemic COVID-19: consider cytokine storm syndromes and immunosuppression Acute myocarditis and pericarditis in children International consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper